在瘤基因驱动的非小细胞肺癌中进行外科手术治疗:当前的策略和未回答的问题
Teja Voruganti1, Rosalyn Marar2, Benjamin Bleiberg1
1Division of Hematology-Oncology, Perelman School of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
概括
可切除非小细胞肺癌 (NSCLC) 的外科手术治疗需要分子测试. 目前正在进行的研究旨在优化向疗法和免疫疗法,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 精准医学是一门精准的医学.
- 胸部外科手术 胸部外科手术
背景情况:
- 术后治疗对于可切除的非小细胞肺癌 (NSCLC) 是至关重要的.
- 分子测试对于指导早期NSCLC治疗至关重要,类似于转移性疾病.
- 基于组织的下一代测序非常重要,因为在早期NSCLC中液体活检敏感性有限.
研究的目的:
- 审查当前的景观和外科手术前期治疗的未来方向在癌基因驱动的NSCLC.
- 突出优化分子测试途径和组织利用的需要.
- 讨论针对性疗法和免疫治疗在早期NSCLC治疗中的演变作用.
主要方法:
- 审查当前的文献和临床试验数据关于外科手术期间的向治疗和免疫治疗NSCLC.
- 分析分子测试的作用,包括下一代测序和分子残留疾病评估.
- 讨论正在进行的研究,研究特定突变 (EGFR,ALK,KRAS,BRAF) 和治疗反应.
主要成果:
- 辅助性奥西默蒂尼布是EGFR突变NSCLC的标准;ALK抑制剂的研究正在进行中.
- 关于术后TKI治疗,分子残留疾病和高危子组,仍然存在未解答的问题.
- 在癌基因驱动的NSCLC中,术后化疗免疫疗法的疗效需要进一步澄清,尽管一些突变,如KRAS/BRAF可能会显示出希望.
结论:
- 优化外科手术期间的策略需要解决针对性疗法和免疫疗法的整合在癌基因驱动的NSCLC.
- 需要进一步的研究来完善治疗决策,并改善可切除NSCLC患者的治疗结果.
- 确定分子残留疾病评估和特定技术知识的作用对于推进外科手术期间护理至关重要.
相关概念视频
02:49Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
01:27Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397